[
  {
    "ts": "2025-12-31T12:18:20+00:00",
    "headline": "Market Chatter: Pfizer, GSK, Others to Raise US Prices on 350 Drugs in 2026",
    "summary": "Pfizer (PFE), Sanofi (SNY), Novartis (NVS), and GSK (GSK) are among the drug makers planning price i",
    "url": "https://finance.yahoo.com/news/market-chatter-pfizer-gsk-others-121820939.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "95a9627e-f7ea-3fe8-b154-c7908365d3d0",
      "content": {
        "id": "95a9627e-f7ea-3fe8-b154-c7908365d3d0",
        "contentType": "STORY",
        "title": "Market Chatter: Pfizer, GSK, Others to Raise US Prices on 350 Drugs in 2026",
        "description": "",
        "summary": "Pfizer (PFE), Sanofi (SNY), Novartis (NVS), and GSK (GSK) are among the drug makers planning price i",
        "pubDate": "2025-12-31T12:18:20Z",
        "displayTime": "2025-12-31T12:18:20Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/market-chatter-pfizer-gsk-others-121820939.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/market-chatter-pfizer-gsk-others-121820939.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "GSK"
            },
            {
              "symbol": "SNY"
            },
            {
              "symbol": "NVS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-31T13:03:00+00:00",
    "headline": "2 Unstoppable Dividend Stocks to Double Up on Right Now",
    "summary": "It's always a great time to buy quality dividend stocks.",
    "url": "https://www.fool.com/investing/2025/12/31/2-dividend-stocks-to-double-up-on-right-now/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "d564fb3a-ecb8-3b08-8d65-73a37e4f84a0",
      "content": {
        "id": "d564fb3a-ecb8-3b08-8d65-73a37e4f84a0",
        "contentType": "STORY",
        "title": "2 Unstoppable Dividend Stocks to Double Up on Right Now",
        "description": "",
        "summary": "It's always a great time to buy quality dividend stocks.",
        "pubDate": "2025-12-31T13:03:00Z",
        "displayTime": "2025-12-31T13:03:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/dcff482f3fd67206088ad0904dfb82da",
          "originalWidth": 1400,
          "originalHeight": 934,
          "caption": "A young and confident investor raising their arm in victory.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/K05.t3KLY3XH75ItQejCiQ--~B/aD05MzQ7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/dcff482f3fd67206088ad0904dfb82da.cf.webp",
              "width": 1400,
              "height": 934,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/WaNUOv1csz2_JkHtpeQKaw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/dcff482f3fd67206088ad0904dfb82da.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/12/31/2-dividend-stocks-to-double-up-on-right-now/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/2-unstoppable-dividend-stocks-double-130300220.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-31T12:32:00+00:00",
    "headline": "Can BMY's Growth Portfolio Drive Top-Line Expansion in 2026?",
    "summary": "Bristol Myers Squibb's growth drugs rose 17% in the first nine months of 2025, helping offset a 16% legacy drug sales decline.",
    "url": "https://finance.yahoo.com/news/bmys-growth-portfolio-drive-top-123200885.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "050132de-e323-38e2-ac8c-e70e56843344",
      "content": {
        "id": "050132de-e323-38e2-ac8c-e70e56843344",
        "contentType": "STORY",
        "title": "Can BMY's Growth Portfolio Drive Top-Line Expansion in 2026?",
        "description": "",
        "summary": "Bristol Myers Squibb's growth drugs rose 17% in the first nine months of 2025, helping offset a 16% legacy drug sales decline.",
        "pubDate": "2025-12-31T12:32:00Z",
        "displayTime": "2025-12-31T12:32:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/52b6d392b63705aefb517365eab38a95",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AZ1NFKr1Arip4UWINeWStw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/52b6d392b63705aefb517365eab38a95.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zL5_evNVQm1N5N.bc6WldQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/52b6d392b63705aefb517365eab38a95.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bmys-growth-portfolio-drive-top-123200885.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bmys-growth-portfolio-drive-top-123200885.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-31T14:34:42+00:00",
    "headline": "Pfizer, GSK Lead U.S. Drugmakers Planning 2026 Price Hikes on 350 Drugs",
    "summary": "List prices to rise an average of 4% despite federal pressure to curb costs.",
    "url": "https://finance.yahoo.com/news/pfizer-gsk-lead-u-drugmakers-143442942.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "60f9e371-cf5c-34d8-8971-8c8928c120be",
      "content": {
        "id": "60f9e371-cf5c-34d8-8971-8c8928c120be",
        "contentType": "STORY",
        "title": "Pfizer, GSK Lead U.S. Drugmakers Planning 2026 Price Hikes on 350 Drugs",
        "description": "",
        "summary": "List prices to rise an average of 4% despite federal pressure to curb costs.",
        "pubDate": "2025-12-31T14:34:42Z",
        "displayTime": "2025-12-31T14:34:42Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/us.finance.gurufocus/08081c8c254eb269c81ba8feeb03a4b4",
          "originalWidth": 500,
          "originalHeight": 500,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vu.kxzmN7yCA.wz8Cs.cHg--~B/aD01MDA7dz01MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/08081c8c254eb269c81ba8feeb03a4b4.cf.webp",
              "width": 500,
              "height": 500,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Brb0J12XOUXl4lathAg3vw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/08081c8c254eb269c81ba8feeb03a4b4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-gsk-lead-u-drugmakers-143442942.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-gsk-lead-u-drugmakers-143442942.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "GLAXF"
            },
            {
              "symbol": "GSK"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-31T16:03:01+00:00",
    "headline": "Pfizer and GSK Lead 2026 U.S. Drug Price Hikes",
    "summary": "Drugmakers Brace for January Price Changes",
    "url": "https://finance.yahoo.com/news/pfizer-gsk-lead-2026-u-160301390.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "8756a28c-f1e5-3ca8-b81b-b694c1bb0bac",
      "content": {
        "id": "8756a28c-f1e5-3ca8-b81b-b694c1bb0bac",
        "contentType": "STORY",
        "title": "Pfizer and GSK Lead 2026 U.S. Drug Price Hikes",
        "description": "",
        "summary": "Drugmakers Brace for January Price Changes",
        "pubDate": "2025-12-31T16:03:01Z",
        "displayTime": "2025-12-31T16:03:01Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/us.finance.gurufocus/08081c8c254eb269c81ba8feeb03a4b4",
          "originalWidth": 500,
          "originalHeight": 500,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vu.kxzmN7yCA.wz8Cs.cHg--~B/aD01MDA7dz01MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/08081c8c254eb269c81ba8feeb03a4b4.cf.webp",
              "width": 500,
              "height": 500,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Brb0J12XOUXl4lathAg3vw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/08081c8c254eb269c81ba8feeb03a4b4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-gsk-lead-2026-u-160301390.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-gsk-lead-2026-u-160301390.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "GSK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-31T19:08:24+00:00",
    "headline": "Drugmakers hike US prices on 350 medicines despite pressure from Trump",
    "summary": "<body><p>STORY: :: Bristol Myers Squibb&nbsp;</p><p>:: File</p><p>Drugmakers plan to raise U.S. prices on at least 350 branded medications in 2026, including vaccines and blockbuster cancer treatment Ibrance.</p><p>:: CVS</p><p>That's according to data provided exclusively to Reuters by healthcare research firm 3 Axis Advisors.</p><p>The hikes come even as&nbsp;the Trump administration is pressuring drugmakers for cuts.</p><p>:: CVS</p><p>The number of price increases is up from the same point last year while the median price hike of four percent is in line with 2025.</p><p>The increases do not reflect any rebates to pharmacy benefit managers and other discounts.</p><p>:: Boehringer Ingelheim</p><p>Drugmakers also plan to cut the list prices on around nine drugs including diabetes treatment Jardiance, which is dropping 40%.</p><p>It is among the 10 drugs for which the U.S. government negotiated a lower price for the Medicare program for people aged 65 and older in 2026.</p><p>:: Pfizer</p><p>A health policy researcher tells Reuters these deals are being announced as transformative when, in fact, they really just nibble around the margins in terms of what is really driving high prices for prescription drugs in the U.S.</p><p>:: CVS</p><p>U.S. patients currently pay by far the most for prescription medicines, often nearly three times more than in other developed nations.</p><p>Pfizer announced the most list price hikes, on around 80 different drugs including cancer drug Ibrance, and its COVID vaccine, which is going up 15%.</p><p>:: Pfizer</p><p>:: File</p><p>Pfizer said in a statement it had adjusted the average list price of its innovative medicines and vaccines for 2026 below the overall rate of inflation.</p><p>:: CVS</p><p>More price hikes and cuts can be expected in early January, which is historically the biggest month for drugmakers to raise prices.</p></body>",
    "url": "https://finance.yahoo.com/video/drugmakers-hike-us-prices-350-190824459.html",
    "source": "Reuters Videos",
    "provider": "yfinance",
    "raw": {
      "id": "4e512a37-8fb5-3392-960d-d2a0c17cb629",
      "content": {
        "id": "4e512a37-8fb5-3392-960d-d2a0c17cb629",
        "contentType": "VIDEO",
        "title": "Drugmakers hike US prices on 350 medicines despite pressure from Trump",
        "description": "<title><body><p>STORY: :: Bristol Myers Squibb </p><p>:: File</p><p>Drugmakers plan to raise U.S. prices on at least 350 branded medications in 2026, including vaccines and blockbuster cancer treatment Ibrance.</p><p>:: CVS</p><p>That's according to data provided exclusively to Reuters by healthcare research firm 3 Axis Advisors.</p><p>The hikes come even as the Trump administration is pressuring drugmakers for cuts.</p><p>:: CVS</p><p>The number of price increases is up from the same point last year while the median price hike of four percent is in line with 2025.</p><p>The increases do not reflect any rebates to pharmacy benefit managers and other discounts.</p><p>:: Boehringer Ingelheim</p><p>Drugmakers also plan to cut the list prices on around nine drugs including diabetes treatment Jardiance, which is dropping 40%.</p><p>It is among the 10 drugs for which the U.S. government negotiated a lower price for the Medicare program for people aged 65 and older in 2026.</p><p>:: Pfizer</p><p>A health policy researcher tells Reuters these deals are being announced as transformative when, in fact, they really just nibble around the margins in terms of what is really driving high prices for prescription drugs in the U.S.</p><p>:: CVS</p><p>U.S. patients currently pay by far the most for prescription medicines, often nearly three times more than in other developed nations.</p><p>Pfizer announced the most list price hikes, on around 80 different drugs including cancer drug Ibrance, and its COVID vaccine, which is going up 15%.</p><p>:: Pfizer</p><p>:: File</p><p>Pfizer said in a statement it had adjusted the average list price of its innovative medicines and vaccines for 2026 below the overall rate of inflation.</p><p>:: CVS</p><p>More price hikes and cuts can be expected in early January, which is historically the biggest month for drugmakers to raise prices.</p></body></title>",
        "summary": "<body><p>STORY: :: Bristol Myers Squibb&nbsp;</p><p>:: File</p><p>Drugmakers plan to raise U.S. prices on at least 350 branded medications in 2026, including vaccines and blockbuster cancer treatment Ibrance.</p><p>:: CVS</p><p>That's according to data provided exclusively to Reuters by healthcare research firm 3 Axis Advisors.</p><p>The hikes come even as&nbsp;the Trump administration is pressuring drugmakers for cuts.</p><p>:: CVS</p><p>The number of price increases is up from the same point last year while the median price hike of four percent is in line with 2025.</p><p>The increases do not reflect any rebates to pharmacy benefit managers and other discounts.</p><p>:: Boehringer Ingelheim</p><p>Drugmakers also plan to cut the list prices on around nine drugs including diabetes treatment Jardiance, which is dropping 40%.</p><p>It is among the 10 drugs for which the U.S. government negotiated a lower price for the Medicare program for people aged 65 and older in 2026.</p><p>:: Pfizer</p><p>A health policy researcher tells Reuters these deals are being announced as transformative when, in fact, they really just nibble around the margins in terms of what is really driving high prices for prescription drugs in the U.S.</p><p>:: CVS</p><p>U.S. patients currently pay by far the most for prescription medicines, often nearly three times more than in other developed nations.</p><p>Pfizer announced the most list price hikes, on around 80 different drugs including cancer drug Ibrance, and its COVID vaccine, which is going up 15%.</p><p>:: Pfizer</p><p>:: File</p><p>Pfizer said in a statement it had adjusted the average list price of its innovative medicines and vaccines for 2026 below the overall rate of inflation.</p><p>:: CVS</p><p>More price hikes and cuts can be expected in early January, which is historically the biggest month for drugmakers to raise prices.</p></body>",
        "pubDate": "2025-12-31T19:08:24Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/uu/api/res/1.2/ZCCRAgQw1H4VhTmnL7SSQA--~B/aD03MjA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://cf-images.us-east-1.prod.boltdns.net/v1/jit/6415665815001/e21a6b31-ae49-498d-95b6-6a3f82b510e7/main/1280x720/54s810ms/match/image.jpg",
          "originalWidth": 1280,
          "originalHeight": 720,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4mDLafeQQaddaMhF3eT6lQ--~B/aD03MjA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://cf-images.us-east-1.prod.boltdns.net/v1/jit/6415665815001/e21a6b31-ae49-498d-95b6-6a3f82b510e7/main/1280x720/54s810ms/match/image.jpg.cf.webp",
              "width": 1280,
              "height": 720,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zoZEDfwosxLKq9swoWWhzQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://cf-images.us-east-1.prod.boltdns.net/v1/jit/6415665815001/e21a6b31-ae49-498d-95b6-6a3f82b510e7/main/1280x720/54s810ms/match/image.jpg.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters Videos",
          "url": "http://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/drugmakers-hike-us-prices-350-190824459.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/drugmakers-hike-us-prices-350-190824459.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-31T18:55:33+00:00",
    "headline": "Sector Update: Health Care Stocks Softer Wednesday Afternoon",
    "summary": "Health care stocks declined Wednesday afternoon, with the NYSE Health Care Index and the State Stree",
    "url": "https://finance.yahoo.com/news/sector-health-care-stocks-softer-185533229.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "f965b588-ff20-3e39-9296-a2cfbed62b52",
      "content": {
        "id": "f965b588-ff20-3e39-9296-a2cfbed62b52",
        "contentType": "STORY",
        "title": "Sector Update: Health Care Stocks Softer Wednesday Afternoon",
        "description": "",
        "summary": "Health care stocks declined Wednesday afternoon, with the NYSE Health Care Index and the State Stree",
        "pubDate": "2025-12-31T18:55:33Z",
        "displayTime": "2025-12-31T18:55:33Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/sector-health-care-stocks-softer-185533229.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/sector-health-care-stocks-softer-185533229.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CORT"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "XLV"
            },
            {
              "symbol": "SNY"
            },
            {
              "symbol": "NVS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-31T20:53:07+00:00",
    "headline": "Sector Update: Health Care Stocks Softer Late Afternoon",
    "summary": "Health care stocks declined late Wednesday afternoon with the NYSE Health Care Index dropping 0.5% a",
    "url": "https://finance.yahoo.com/news/sector-health-care-stocks-softer-205307207.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "59789c3d-a41f-3f4d-b75a-2ba11538cfec",
      "content": {
        "id": "59789c3d-a41f-3f4d-b75a-2ba11538cfec",
        "contentType": "STORY",
        "title": "Sector Update: Health Care Stocks Softer Late Afternoon",
        "description": "",
        "summary": "Health care stocks declined late Wednesday afternoon with the NYSE Health Care Index dropping 0.5% a",
        "pubDate": "2025-12-31T20:53:07Z",
        "displayTime": "2025-12-31T20:53:07Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/sector-health-care-stocks-softer-205307207.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/sector-health-care-stocks-softer-205307207.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "XLV"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "CORT"
            },
            {
              "symbol": "AXSM"
            },
            {
              "symbol": "SNY"
            },
            {
              "symbol": "NVS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-31T22:50:00+00:00",
    "headline": "Where Will Pfizer Be in 5 Years?",
    "summary": "Pfizer's stock is down roughly 60% from its late 2021 highs, but the drug giant is working to innovate its way back into the big leagues.",
    "url": "https://www.fool.com/investing/2025/12/31/where-will-pfizer-be-in-5-years/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "6685c427-5739-367c-907e-3c33da1d7243",
      "content": {
        "id": "6685c427-5739-367c-907e-3c33da1d7243",
        "contentType": "STORY",
        "title": "Where Will Pfizer Be in 5 Years?",
        "description": "",
        "summary": "Pfizer's stock is down roughly 60% from its late 2021 highs, but the drug giant is working to innovate its way back into the big leagues.",
        "pubDate": "2025-12-31T22:50:00Z",
        "displayTime": "2025-12-31T22:50:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/937171cca65ea33229df2e5cb714eb47",
          "originalWidth": 1200,
          "originalHeight": 800,
          "caption": "A tape measure with a pile of pills.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vRED2ykQeHtNLMaZAt0PSw--~B/aD04MDA7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/937171cca65ea33229df2e5cb714eb47.cf.webp",
              "width": 1200,
              "height": 800,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0wkeXJTtcklefjagtRoNFQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/937171cca65ea33229df2e5cb714eb47.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/12/31/where-will-pfizer-be-in-5-years/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/where-pfizer-5-years-225000637.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-31T15:28:00+00:00",
    "headline": "Why Wall Street Gave Up on Pfizer—and Why That May Be a Mistake",
    "summary": "With activist investors gone and revenue stabilizing, the undervalued pharmaceutical giant offers a compelling chance for value investors in the coming year.",
    "url": "https://www.marketbeat.com/originals/why-wall-street-gave-up-on-pfizerand-why-that-may-be-a-mistake/?utm_source=yahoofinance&utm_medium=yahoofinance",
    "source": "MarketBeat",
    "provider": "yfinance",
    "raw": {
      "id": "697cd6c1-86c6-34d5-8c4e-c8d8724a3b10",
      "content": {
        "id": "697cd6c1-86c6-34d5-8c4e-c8d8724a3b10",
        "contentType": "STORY",
        "title": "Why Wall Street Gave Up on Pfizer—and Why That May Be a Mistake",
        "description": "",
        "summary": "With activist investors gone and revenue stabilizing, the undervalued pharmaceutical giant offers a compelling chance for value investors in the coming year.",
        "pubDate": "2025-12-31T15:28:00Z",
        "displayTime": "2025-12-31T15:28:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/marketbeat_955/a82ecbb8d33ef1b499b4a7b411928b86",
          "originalWidth": 1200,
          "originalHeight": 675,
          "caption": "Pfizer research laboratory with branded display and vaccine vials, illustrating a major pharmaceutical company rebuilding value and pipeline strength.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4vTdyP1QI9_UKlQEofKPwQ--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/marketbeat_955/a82ecbb8d33ef1b499b4a7b411928b86.cf.webp",
              "width": 1200,
              "height": 675,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/N1iH5NYlV0hlbc5BuicF6A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/marketbeat_955/a82ecbb8d33ef1b499b4a7b411928b86.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MarketBeat",
          "url": "https://www.marketbeat.com/"
        },
        "canonicalUrl": {
          "url": "https://www.marketbeat.com/originals/why-wall-street-gave-up-on-pfizerand-why-that-may-be-a-mistake/?utm_source=yahoofinance&utm_medium=yahoofinance",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/why-wall-street-gave-pfizer-152800660.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]